Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$31.65 +0.25 (+0.80%)
At close: Oct 23, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Gains from Equity Investments (2017 - 2020)

Updated

Analysis

Lakefront Biotherapeutics (LKFT) Gains from Equity Investments (2017 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Lakefront Biotherapeutics 2.09 Bn 2.09 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 9.65 Mn
Dec 31, 2019 26.74 Mn
Sep 30, 2019 11.15 Mn
Mar 31, 2019 8.95 Mn
Dec 31, 2018 8.40 Mn
Sep 30, 2018 9.69 Mn
Mar 31, 2018 8.51 Mn
Dec 31, 2017 12.18 Mn
Sep 30, 2017 7.49 Mn
Mar 31, 2017 6.26 Mn
API Access

Lakefront Biotherapeutics Gains from Equity Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=LKFT&period=max&api_key=YOUR_API_KEY